{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:00:18Z","timestamp":1791489618432,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":221,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101366","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:38:47Z","timestamp":1787107127000},"page":"101366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A direct comparison of butyrate, 4-phenylbutyrate, and \u03b2-hydroxybutyrate in an in vitro tumor therapy model"],"prefix":"10.1016","volume":"49","author":[{"given":"Haralambia","family":"Katsika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Purps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Montag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8458-0407","authenticated-orcid":false,"given":"Fiona","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Schwenkschuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Glei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix Benjamin","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7785-5846","authenticated-orcid":false,"given":"Ren\u00e9","family":"Thierbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ctarc.2026.101366_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101366_bib0002","doi-asserted-by":"crossref","first-page":"8367","DOI":"10.3390\/molecules27238367","article-title":"Natural products as anticancer agents: current status and future perspectives","volume":"27","author":"Naeem","year":"2022","journal-title":"Molecules."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101366_bib0003","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2024.5632","article-title":"Butyrate as a promising therapeutic target in cancer: from pathogenesis to clinic (Review)","volume":"64","author":"Sun","year":"2024","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101366_bib0004","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.molcel.2012.08.033","article-title":"The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation","volume":"48","author":"Donohoe","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ctarc.2026.101366_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101312","article-title":"HDAC inhibitors: targets for tumor therapy, immune modulation and lung diseases","volume":"16","author":"Shanmugam","year":"2022","journal-title":"Transl. Oncol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101366_bib0006","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/gut.28.10.1221","article-title":"Short chain fatty acids in human large intestine, portal, hepatic and venous blood","volume":"28","author":"Cummings","year":"1987","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101366_bib0007","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ajpath.2023.06.007","article-title":"The role of gut microbiome-derived short-chain fatty acid butyrate in hepatobiliary diseases","volume":"193","author":"Pant","year":"2023","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ctarc.2026.101366_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2024.125743","article-title":"Quantitation of circulating short-chain fatty acids in small volume blood samples from animals and humans","volume":"272","author":"Fristedt","year":"2024","journal-title":"Talanta"},{"issue":"6","key":"10.1016\/j.ctarc.2026.101366_bib0009","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s002800050922","article-title":"Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats","volume":"43","author":"Egorin","year":"1999","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.ctarc.2026.101366_bib0010","unstructured":"Ammonaps. 2022 [cited 2025 06.04.2025]; Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/ammonaps."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101366_bib0011","first-page":"2292","article-title":"A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies","volume":"7","author":"Gilbert","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101366_bib0012","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/acs.chemrestox.7b00149","article-title":"Potential of phenylbutyrate as adjuvant chemotherapy: an overview of cellular and molecular anticancer mechanisms","volume":"30","author":"Al-Keilani","year":"2017","journal-title":"Chem. Res. Toxicol."},{"issue":"22","key":"10.1016\/j.ctarc.2026.101366_bib0013","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.3390\/nu14224932","article-title":"Molecular mechanisms for ketone body metabolism, signaling functions, and therapeutic potential in cancer","volume":"14","author":"Hwang","year":"2022","journal-title":"Nutrients."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101366_bib0014","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3390\/cancers14020287","article-title":"Toward tumor fight and tumor microenvironment remodeling: PBA induces cell cycle arrest and reduces tumor hybrid cells' Pluripotency in bladder cancer","volume":"14","author":"Rubio","year":"2022","journal-title":"Cancers. (Basel)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101366_bib0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/jcb.20173","article-title":"Sodium 4-phenylbutyrate induces apoptosis of human lung carcinoma cells through activating JNK pathway","volume":"93","author":"Zhang","year":"2004","journal-title":"J. Cell Biochem."},{"issue":"6116","key":"10.1016\/j.ctarc.2026.101366_bib0016","first-page":"211","article-title":"Suppression of oxidative stress by \u03b2-hydroxybutyrate, an endogenous histone deacetylase inhibitor","volume":"339","author":"Shimazu","year":"2013","journal-title":"Sci. (1979)"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101366_bib0017","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.molcel.2016.03.036","article-title":"Metabolic regulation of gene expression by histone lysine \u03b2-hydroxybutyrylation","volume":"62","author":"Xie","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ctarc.2026.101366_bib0018","doi-asserted-by":"crossref","DOI":"10.1038\/srep32966","article-title":"Improvement of the BALB\/c-3T3 cell transformation assay: a tool for investigating cancer mechanisms and therapies","volume":"6","author":"Poburski","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101366_bib0019","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1186\/s12885-021-08354-x","article-title":"Metformin alters therapeutic effects in the BALB\/c tumor therapy model","volume":"21","author":"Meyer","year":"2021","journal-title":"BMC. Cancer"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101366_bib0020","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.3390\/biom11121831","article-title":"Butyrate and metformin affect energy metabolism independently of the metabolic phenotype in the tumor therapy model","volume":"11","author":"Meyer","year":"2021","journal-title":"Biomolecules."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101366_bib0021","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mrgentox.2012.01.009","article-title":"Photo catalogue for the classification of foci in the BALB\/c 3T3 cell transformation assay","volume":"744","author":"Sasaki","year":"2012","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ctarc.2026.101366_bib0022","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"7\u20138","key":"10.1016\/j.ctarc.2026.101366_bib0023","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1007\/s10495-023-01850-4","article-title":"Sodium butyrate induces ferroptosis in endometrial cancer cells via the RBM3\/SLC7A11 axis","volume":"28","author":"Wang","year":"2023","journal-title":"Apoptosis."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101366_bib0024","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10565-020-09518-4","article-title":"Sodium butyrate modulates gut microbiota and immune response in colorectal cancer liver metastatic mice","volume":"36","author":"Ma","year":"2020","journal-title":"Cell Biol. Toxicol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101366_bib0025","first-page":"139","article-title":"Sodium phenylbutyrate inhibits tumor growth and the epithelial-mesenchymal transition of oral squamous cell carcinoma In vitro and In vivo","volume":"33","author":"Qian","year":"2018","journal-title":"Cancer BiOther Radiopharm."},{"issue":"7908","key":"10.1016\/j.ctarc.2026.101366_bib0026","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-022-04649-6","article-title":"\u03b2-hydroxybutyrate suppresses colorectal cancer","volume":"605","author":"Dmitrieva-Posocco","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.ctarc.2026.101366_bib0027","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40170-018-0180-9","article-title":"Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation","volume":"6","author":"Bartmann","year":"2018","journal-title":"Cancer Metab."},{"issue":"21","key":"10.1016\/j.ctarc.2026.101366_bib0028","first-page":"24","article-title":"Sodium butyrate enhances the cytotoxic effect of etoposide in HDACi-sensitive and HDACi-resistant transformed cells","author":"Gnedina","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101366_bib0029","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.21873\/anticanres.13220","article-title":"Histone deacetylase inhibitors and anaplastic thyroid carcinoma","volume":"39","author":"Spartalis","year":"2019","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101366_bib0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12886-019-1056-7","article-title":"Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure","volume":"19","author":"Qiu","year":"2019","journal-title":"BMC. Ophthalmol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101366_bib0031","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0009-8981(89)90231-3","article-title":"Pharmacokinetic study of butyric acid administered in vivo as sodium and arginine butyrate salts","volume":"181","author":"Daniel","year":"1989","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101366_bib0032","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat, Rev, Drug Discov."},{"issue":"20","key":"10.1016\/j.ctarc.2026.101366_bib0033","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1523\/JNEUROSCI.5214-12.2013","article-title":"Specific acetylation of p53 by HDAC inhibition prevents DNA damage-induced apoptosis in neurons","volume":"33","author":"Brochier","year":"2013","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101366_bib0034","article-title":"PBA preferentially impairs cell survival of glioblastomas carrying mutp53 by reducing its expression level, stabilizing wtp53","volume":"10","author":"Romeo","year":"2020","journal-title":"Downregulating Mevalonate Kinase Dysregulating UPR. Biomol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101366_bib0035","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1002\/1878-0261.13060","article-title":"Mechanistic insights into p53-regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells","volume":"15","author":"Marx","year":"2021","journal-title":"Mol. Oncol."},{"issue":"28","key":"10.1016\/j.ctarc.2026.101366_bib0036","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/onc.2016.502","article-title":"Census and evaluation of p53 target genes","volume":"36","author":"Fischer","year":"2017","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101366_bib0037","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1207\/S15327914NC4602_14","article-title":"Sodium butyrate inhibits cell growth and stimulates p21WAF1\/CIP1 protein in human colonic adenocarcinoma cells independently of p53 status","volume":"46","author":"Kobayashi","year":"2003","journal-title":"Nutr. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101366_bib0038","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s13277-015-3781-8","article-title":"Phenylbutyrate-a pan-HDAC inhibitor-suppresses proliferation of glioblastoma LN-229 cell line","volume":"37","author":"Kusaczuk","year":"2016","journal-title":"Tumour. Biol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101366_bib0039","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death. Differ."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101366_bib0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3390\/genes10020094","article-title":"On the interplay of the DNA replication program and the Intra-S phase checkpoint pathway","volume":"10","author":"Ciardo","year":"2019","journal-title":"Genes. (Basel)"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101366_bib0041","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1443-9573.2005.00229.x","article-title":"Effects of sodium phenylbutyrate on differentiation and induction of the P21WAF1\/CIP1 anti-oncogene in human liver carcinoma cell lines","volume":"6","author":"Meng","year":"2005","journal-title":"Chin. J. Dig. Dis."},{"issue":"17","key":"10.1016\/j.ctarc.2026.101366_bib0042","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/00029330-200809010-00023","article-title":"Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate","volume":"121","author":"Wang","year":"2008","journal-title":"Chin. Med. J. (Engl)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101366_bib0043","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3748\/wjg.v18.i1.79","article-title":"Growth inhibitory effect of 4-phenyl butyric acid on human gastric cancer cells is associated with cell cycle arrest","volume":"18","author":"Li","year":"2012","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101366_bib0044","doi-asserted-by":"crossref","first-page":"795","DOI":"10.31557\/APJCP.2022.23.3.795","article-title":"Effect of sodium butyrate on p16INK4a, p14ARF, p15INK4b, class I HDACs (HDACs 1, 2, 3) class II HDACs (HDACs 4, 5, 6), cell growth inhibition and apoptosis induction in pancreatic cancer AsPC-1 and colon cancer HCT-116 cell lines","volume":"23","author":"Sanaei","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.ctarc.2026.101366_bib0045","article-title":"Histone deacetylase inhibitor phenylbutyrate exaggerates heart failure in pressure overloaded mice independently of HDAC inhibition","volume":"6","author":"Ma","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101366_bib0047","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.2147\/OTT.S101794","article-title":"Sodium phenylbutyrate antagonizes prostate cancer through the induction of apoptosis and attenuation of cell viability and migration","volume":"9","author":"Xu","year":"2016","journal-title":"Onco Targets. Ther."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101366_bib0048","first-page":"3941","article-title":"Butyrate inhibits the proliferation and induces the apoptosis of colorectal cancer HCT116 cells via the deactivation of mTOR\/S6K1 signaling mediated partly by SIRT1 downregulation","volume":"19","author":"Cao","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101366_bib0049","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/CAD.0000000000000966","article-title":"Metformin induces caspase-dependent and caspase-independent apoptosis in human bladder cancer T24 cells","volume":"31","author":"Jang","year":"2020","journal-title":"Anticancer Drugs"},{"issue":"20","key":"10.1016\/j.ctarc.2026.101366_bib0050","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1038\/sj.onc.1206454","article-title":"Apoptosis and melanoma chemoresistance","volume":"22","author":"Soengas","year":"2003","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101366_bib0052","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/icb.1979.54","article-title":"The inhibition of malignant cell growth by ketone bodies","volume":"57","author":"Magee","year":"1979","journal-title":"Aust. J. Exp. Biol. Med. Sci."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101366_bib0053","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1215\/S1152851704000183","article-title":"Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic study","volume":"7","author":"Phuphanich","year":"2005","journal-title":"Neuro Oncol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101366_bib0054","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10637-006-9017-4","article-title":"Phase I dose escalation clinical trial of phenylbutyrate sodium administered twice daily to patients with advanced solid tumors","volume":"25","author":"Camacho","year":"2007","journal-title":"Invest. New Drugs"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:38:07Z","timestamp":1791488287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":52,"alternative-id":["S2468294226002777"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101366","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A direct comparison of butyrate, 4-phenylbutyrate, and \u03b2-hydroxybutyrate in an in vitro tumor therapy model","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101366"}}